ACADIA Pharmaceuticals Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ACAD Nasdaq 2834 http://www.acadia-pharm.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ACADIA Pharmaceuticals Inc.

Breakeven On The Horizon For ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) - May 19th, 2022 1:01 pm
Acadia (ACAD) Q1 Earnings & Revenues Fall Shy of Estimates - May 5th, 2022 2:06 pm
Acadia Pharmaceuticals (ACAD) Reports Q1 Loss, Lags Revenue Estimates - May 4th, 2022 10:15 pm
Acadia Pharmaceuticals Reports First Quarter 2022 Financial Results - May 4th, 2022 8:05 pm
Acadia Pharmaceuticals to Present at Upcoming Investor Conferences - May 3rd, 2022 8:05 pm
Acadia Pharmaceuticals Announces FDA Advisory Committee Meeting to Review Resubmission of Supplemental New Drug Application for NUPLAZID® (pimavanserin) for the Treatment of Alzheimer’s Disease Psychosis Scheduled for June 17, 2022 - May 2nd, 2022 8:05 pm
Zymeworks Inc. (ZYME) Surges 23.2%: Is This an Indication of Further Gains? - May 2nd, 2022 10:36 am
Analysts Estimate Acadia Pharmaceuticals (ACAD) to Report a Decline in Earnings: What to Look Out for - Apr 27th, 2022 7:03 pm
9 Healthcare Stocks to Invest In Today According to Stanley Druckenmiller - Apr 21st, 2022 1:09 pm
Acadia Pharmaceuticals to Announce First Quarter 2022 Financial Results on May 4, 2022 - Apr 21st, 2022 1:00 pm
10 Trending Stocks to Watch Today - Apr 19th, 2022 9:52 pm
Analysts Say Acadia's Negative Pain Data Increases Focus On Pimavanserin For Alzheimer's-Related Psychosis - Apr 19th, 2022 7:49 pm
Acadia (ACAD) Stock Down as Pain Candidate Misses Study Goal - Apr 19th, 2022 4:02 pm
Why Acadia Pharma Shares Are Falling Today - Apr 19th, 2022 10:10 am
Acadia Pharmaceuticals Announces Top-Line Results from Phase 2 Study Evaluating ACP-044 for the Treatment of Acute Postoperative Pain - Apr 18th, 2022 8:05 pm
Why Is Acadia (ACAD) Up 1% Since Last Earnings Report? - Mar 30th, 2022 3:30 pm
Acadia Pharmaceuticals Stock Shows Market Leadership With Jump To 91 RS Rating - Mar 25th, 2022 6:26 pm
Acadia Pharmaceuticals to Present Late-Breaking Data at the 2022 American Academy of Neurology Annual Meeting (AAN) - Mar 22nd, 2022 1:00 pm
Acadia Pharmaceuticals to Present at the 1st Annual Needham Virtual Neuroscience Forum on March 16, 2022 - Mar 10th, 2022 9:05 pm
Acadia (ACAD) Stock Up on FDA's Action Date for Nuplazid sNDA - Mar 10th, 2022 4:50 pm